ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 19 for:    ipilimumab AND Bristol AND prostate

A Study to Evaluate Preliminary Safety and Efficacy of Nivolumab Plus Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02985957
Recruitment Status : Active, not recruiting
First Posted : December 7, 2016
Last Update Posted : January 14, 2019
Sponsor:
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : June 30, 2021
  Estimated Study Completion Date : March 24, 2022